Skip to content

Prostate Biomarkers in Men Consuming Tomato Products

Prostate Biomarkers in Men Consuming Tomato Products

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02292524
Enrollment
33
Registered
2014-11-17
Start date
2002-05-31
Completion date
2004-10-31
Last updated
2014-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Brief summary

Prostate Biomarkers in Men Consuming Tomato Products

Detailed description

Participants completed a minimum week-long washout period without consumption of tomato products prior to randomization to one of four dietary interventions. Men were randomized to one of the following dietary interventions: a controlled low lycopene diet (≤ 5 mg/d from foods), daily Prego® spaghetti sauce, daily V8® vegetable juice, or daily Campbell's® Tomato Soup. Each of the tomato products provided between 25 and 35 mg lycopene per day. In order to provide this dietary intervention in typical serving sizes in the context of a usual diet but devoid of other tomato sources, participants kept daily logs documenting compliance with the intervention product and a tomato-restricted diet from enrollment to the day of surgery (\ 3 weeks). Study participants were asked to complete an abbreviated dietary history questionnaire (to establish typical consumption patterns of various tomato products) and two separate 3-day diet food records, once during the washout and once during the intervention period. Blood and 24-hour urine samples were obtained at two time points, after the one-week washout phase and at the end of the dietary intervention period. Fresh prostate samples were obtained at time of surgery.

Interventions

OTHERCommercially-available tomato food product

Each of the three tomato food products (juice, soup, sauce) provided 25-35 mg lycopene/day.

Sponsors

Schwartz, Steven, PhD
CollaboratorUNKNOWN
Ohio State University Comprehensive Cancer Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

To be included in this study, men must: * Have biopsy-proven, clinically localized adenocarcinoma of the prostate based on standard presurgical staging studies * Have chosen to undergo a radical prostatectomy for treatment of their disease after the medical team has presented all possible treatment options * Have kidney and liver enzymes, CBC, and PT/PTT/INR within normal limits * Agree to sign consent form prior to enrollment in the study

Exclusion criteria

Men may not participate in this if they: * Are currently taking lycopene or alternative dietary supplements * Have a history of digestive or malabsorptive disorders, metabolic enzyme deficiencies, or other disorders requiring special dietary modifications (controlled type II diabetes mellitus was allowed)

Design outcomes

Primary

MeasureTime frame
Measure carotenoids, including lycopene and its isomers, in blood (umol/L) and prostate tissue (nmol/g) of men after three weeks of consuming V8 vegetable juice, condensed tomato soup or tomato sauce.Day 0 and End of Study (an average of 23 days)

Secondary

MeasureTime frameDescription
Measure histobiomarkers in the prostate related to aggressive disease including Gleason Grade (number 1 - 10), tumor volume (weight) , and vascular endothelial growth factor expression (ng/mL)Day 0 and End of Study (an average of 23 days)Measure histobiomarkers in the prostate related to aggressive disease including Gleason Grade, tumor volume, and vascular endothelial growth factor expression
Measure biomarkers related to prostate cancer in controls and men consuming tomato food products prior to surgery. These biomarkers include plasma insulin like growth factor (ng/mL) and plasma prostate specific antigen (ng/mL)Day 0 and End of study (an average of 23 days)Measure biomarkers related to prostate cancer in controls and men consuming tomato food products prior to surgery. These biomarkers include plasma insulin like growth factor (ng/mL) and plasma prostate specific antigen (ng/mL)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026